This topic contains a solution. Click here to go to the answer

Author Question: A 51-year-old female patient has been receiving doxorubicin (Adriamycin) for metastatic breast ... (Read 39 times)

JGIBBSON

  • Hero Member
  • *****
  • Posts: 538
A 51-year-old female patient has been receiving doxorubicin (Adriamycin) for metastatic breast cancer. Her medical record indicates she has cardiomyopathy and a cumulative dose of 300 mg/m2 of doxorubicin.
 
  Which of the following measures would help limit the severity of the cardiomyopathy in this patient?
  A) A reduced dose
  B) A single large dose instead of multiple doses
  C) The use of dexrazoxane in conjunction with doxorubicin
  D) Meticulous monitoring during drug administration

Question 2

A 39-year-old woman is receiving doxorubicin for the treatment of cancer. After each treatment, the patient has acute nausea and vomiting accompanied by a slightly increased heart rate. The nurse will advise her to
 
  A) perform relaxation techniques after the treatments.
  B) make an appointment for cardiac function tests.
  C) take the drug only at bedtime.
  D) perform light exercise after administration of the drug.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

leeeep

  • Sr. Member
  • ****
  • Posts: 315
Answer to Question 1

C

Answer to Question 2

A




JGIBBSON

  • Member
  • Posts: 538
Reply 2 on: Jul 23, 2018
YES! Correct, THANKS for helping me on my review


Jsherida

  • Member
  • Posts: 314
Reply 3 on: Yesterday
Excellent

 

Did you know?

Approximately 25% of all reported medication errors result from some kind of name confusion.

Did you know?

The effects of organophosphate poisoning are referred to by using the abbreviations “SLUD” or “SLUDGE,” It stands for: salivation, lacrimation, urination, defecation, GI upset, and emesis.

Did you know?

The shortest mature adult human of whom there is independent evidence was Gul Mohammed in India. In 1990, he was measured in New Delhi and stood 22.5 inches tall.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

For a complete list of videos, visit our video library